Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium (Q43011791)
Jump to navigation
Jump to search
scientific article published in September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium |
scientific article published in September 2010 |
Statements
1 reference
Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium (English)
1 reference
John D Hainsworth
1 reference
Jeffrey R Infante
1 reference
David R Spigel
1 reference
James D Peyton
1 reference
Dana S Thompson
1 reference
Cassie M Lane
1 reference
Bobby L Clark
1 reference
Mark S Rubin
1 reference
David F Trent
1 reference
Howard A Burris
1 reference
1 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference